Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IGHD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NOVA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
URB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1QTNF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAIR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KITLG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIR-FIGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UGT3A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR51M1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXB-AS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCORL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNIK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100PBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on